Edward H. van der Horst

HER3 Is a Determinant for Poor Prognosis in Melanoma

Markus Reschke, Daniela Mihic‐Probst, Edward H. van der Horst et al. · Clinical Cancer Research · 2008 · 166 citations · Full text

Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs

Christopher R. Behrens, Edward Ha, Lawrence Chinn et al. · Molecular Pharmaceutics · 2015 · 150 citations · Full text

Afford Adcs, Immunology, Immunotherapeutics +19

Metastatic properties and genomic amplification of the tyrosine kinase gene <i>ACK1</i>

Edward H. van der Horst, Yan Degenhardt, Astrid Strelow et al. · Proceedings of the National Academy of Sciences · 2005 · 145 citations · Full text

Molecular Biology, Ack1 Gene, Cancer Biology +21

Antitumor activity of an anti‐<scp>CD</scp>98 antibody

Gregory M. Hayes, Lawrence Chinn, Joseph M. Cantor et al. · International Journal of Cancer · 2014 · 69 citations · Full text

Antitumor Activity, Immunology, Care Carboplatin +17

Discovery of Fully Human Anti-MET Monoclonal Antibodies with Antitumor Activity against Colon Cancer Tumor Models In Vivo

Edward H. van der Horst, Lawrence Chinn, Min Wang et al. · Neoplasia · 2009 · 62 citations · Full text